Crown Bioscience

Crown Bioscience provides drug discovery solutions to pharmaceutical companies for cancer and metabolic diseases.

Crown Bioscience has established multiple in vivo assay systems to evaluate novel anti-cancer compounds. Each assay is designed to understand specific aspects of drug property and its mechanism of action. By accessing their comprehensive capability, their customers can advance development programs in a timely and cost-effective manner. Their highly experienced preclinical team is; focused solely on oncology, works with you to choose the most appropriate study design and screening method for an investigational agent.